Key facts
- This page summarizes Amir David Tal's Form 3 filing for CANNAPHARMARX, INC. (CPMD).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 10 Apr 2025, 21:43.
Amir David Tal - 31 Mar 2025 Form 3 Insider Report for CANNAPHARMARX, INC. (CPMD)
- Reporting relationship
- Right to appoint directors
- Issuer ticker
- CPMD
- Reported as of
- 31 Mar 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Amir Tal
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Amir David Tal filed Form 3 for CANNAPHARMARX, INC. (CPMD) on 10 Apr 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,368,212
- Date
- 31 Mar 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPMD
holding
Derivative
Series C Preferred
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- Footnotes
- F1
CPMD
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- Footnotes
- F1
CPMD
holding
Derivative
Convertible notes
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Under the terms of the LTB transaction with the Issuer, Amir Tal was issued: (i) 1,3612,481 warrants entitling the holder to purchase one share of common stock of the Company at $0.02 per share until November 22, 2028; (ii) a $450,000 promissory note payable to Mr. Amir Tal; (iii) $212,555.43 in convertible notes at an exercise price of the lowest 60 day share price before the period end; and (iv) 100,000 Class C preferred shares each convertible into 1,250 shares of common stock. Mr. Tal is not permitted to, at any time, to own more than 4.99% of the outstanding shares of common stock of the Company.